Carlsmed $CARL is a fascinating company that's using AI to make spine surgery better with custom implants, which could dramatically improve patient outcomes. The global spinal implant market is a multi-billion dollar industry, so the total addressable market is huge. However, it's always wise to do thorough research before getting too excited. In this video, we'll dive into Carlsmed's AI IPO and see if it's a worthy addition to our disruptive technology portfolio. We'll also look at a second AI IPO that wants to be the next Coreweave - WhiteFiber $WYFI
Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/tHZz2btBKkA.
